Active Ingredient History

  • Now
Vildagliptin, sold under the brand name Galvus and others, is an oral anti-hyperglycemic agent of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.   Wikipedia

  • Mol. Mass: 303.41
  • ALogP: 1.17
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

1-(((3-hydroxy-1-adamantyl)amino)acetyl)-2-cyanopyrrolidine | (2s)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile | equa | galvus | haaa-2-cyanopyrrolidine | jalra | laf237 | laf 237 | laf-237 | nvp-laf237 | nvp-laf-237 | vidagliptin | vildagliptin | vildagliptin hcl | vildagliptin hydrochloride | vildagliptin / metformin hydrochloride | xiliarx


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue